Design of the START-trial: STimulation of ARTeriogenesis Using Subcutaneous Application of GM-CSF as a New Treatment for Peripheral Vascular Disease. A Randomized, Double-Blind, Placebo-Controlled Trial

Vascular Medicine - United Kingdom
doi 10.1191/1358863x03vm496oa
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

Addiction
MedicinePsychiatryMental Health
2013English

A Randomized, Double-Blind, Placebo-Controlled Trial of Cyproheptadine for Appetite Stimulation in Cystic Fibrosis

Jornal de Pediatria
Child HealthPediatricsPerinatology
2012English

A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression

Psychopharmacology
Pharmacology
2013English

Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2000English

Impact of Antioxidant Treatment on DNA Fragmentation Index: A Double-Blind Placebo-Controlled Randomized Trial

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2018English

The Protocol for a Multisite, Double Blind, Randomized, Placebo-Controlled Trial of Axillary Nerve Stimulation for Chronic Shoulder Pain

Trials
MedicinePharmacology
2020English

Journal Club: A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Treat Alzheimer Disease

Neurology
Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy